Fountain Life Funding, Investors & Competitors

Fountain Life has raised $115M across 4 funding rounds, most recently a $18M Series B in August 2025.

Last Fountain Life funding round

$18M

Series B · Aug 2025

Cumulative funding Fountain Life raised

$115M

across 4 funding rounds

Key investors in Fountain Life

  • Eos Venture Partners
  • Tony Robbins
  • Peter Diamandis
  • Bhupendra Modi
  • Newcross Healthcare
  • Todd R. Wanek

Fountain Life Overview

About Fountain Life

Fountain Life is a longevity clinic offering AI-driven diagnostics including full-body MRI, CT scans, blood panels, and whole-genome sequencing. Dallas-headquartered Fountain Life pairs results with physician-led care teams for personalized prevention plans in cardiovascular, cancer, and metabolic health.


Founded

2020

HQ

United StatesUnited States

Status

Privately held

Customer focus

B2C

Revenue model

Services

Fountain Life Funding History

Fountain Life has raised a total of $115M across 4 funding rounds.

Fountain Life's first fundraising round was a $2M seed round in January 2021. The most recent completed round was a $18M Series B in August 2025.

Fountain Life funding rounds

Fountain Life funding rounds
DateStageInvestorsRaisedDeal Summary
Aug 2025Series BEos Venture Partners (lead); Todd R. Wanek; Tony Robbins; Peter Diamandis; Bhupendra Modi$18MFountain Life, a longevity-focused health company co-founded by Dr. William Kapp, Tony Robbins, and Dr. Peter Diamandis, raised $18 million in a Series B round on August 13-14, 2025, led by Eos Venture Partners with participation from existing board members and investors including Todd Wanek and B.K. Modi. The company originated from a 2020 merger between Kapp’s Longevity Performance Center in Naples, Florida, and Robbins and Diamandis’ Fountain Therapeutics stem cell startup. It operates centers in locations such as Naples, Westchester (New York), Orlando, and Dallas, specializing in early detection via advanced diagnostics like blood tests, full-body scans monitoring over 100 biomarkers, health optimization, and regenerative therapies, with results tracked via an AI-powered app called Zori. Membership is subscription-based and priced at around $30,000 annually for full services including quarterly testing and medical support, or $10,000-$10,500 for testing-only packages, with tiered programs like CORE, APEX, and EPIC. The company previously raised an $80 million Series A, bringing total funding to about $108 million. The new capital will fund expansion, including a Houston center opening in December 2025 and planned locations in Los Angeles and Miami for Q2 2026. Fountain Life aims to shift healthcare from reactive to proactive by making advanced diagnostics more accessible, planning to train external medical facilities on its methodologies to reduce costs. It positions itself in the growing preventive healthcare market driven by demand for early disease detection.
Nov 2023Series AEos Venture Partners (lead)$80MFountain Life is a preventative health and longevity company founded in 2020 by Dr. William Kapp, Tony Robbins, Peter Diamandis, and others, focusing on transforming healthcare from reactive to proactive through precision diagnostics, AI technologies, and early detection of diseases like cancer, cardiac, metabolic, and neurodegenerative conditions. It operates centers in locations including Orlando, Dallas, Miami, Houston, and White Plains, offering tiered membership programs such as CORE, APEX, and EPIC with annual subscriptions priced at $21,500 or testing packages at $10,500, emphasizing predictive, preventive, personalized, and data-driven care. The company secured a $15M investment on December 15, 2022, from Eos Venture Partners and Newcross Healthcare to support U.S. and global expansion, integrated insurance business, and advancements in home care. Later, Fountain Life raised an $18M Series B in August 2025 led by Eos Venture Partners (EOS Ventures), with participation from board members like Todd Wanek and B.K. Modi, following a prior $80M Series A, bringing total funding to about $108M; funds aimed at expanding centers to Houston, Los Angeles, and Miami. The company positions itself in the longevity and InsurTech space, partnering with global insurers via Eos to impact healthcare access.
Dec 2022Series AEos Venture Partners (lead); Newcross Healthcare (lead)$15MFountain Life is a preventative health and longevity company founded in 2020 by Tony Robbins, Peter Diamandis, Dr. Bob Hariri, and Dr. William Kapp, focused on transforming healthcare from reactive to proactive through precision diagnostics, AI technologies, and advanced testing to detect asymptomatic diseases early, including cancer, cardiac, metabolic, and neurodegenerative conditions. The company offers membership services via centers in locations such as Naples, FL; White Plains, NY; Dallas, TX; and Rishikesh, India, with tele-health options and plans for further U.S. and global expansion. It also operates an integrated health insurance business. On December 15, 2022, Fountain Life raised $15 million in venture funding from Eos Venture Partners and Newcross Healthcare to support its product development, geographic expansion, and transformation of the healthcare ecosystem, including enhanced home care availability. Eos Venture Partners, a leading InsurTech investor, and Newcross Healthcare, a UK-based expert in healthcare treatment and care at home, participated as strategic partners. The funding aims to democratize access to advanced medical technology and advance wellness-focused preventative diagnostics.
Jan 2021Seed-$2M-

Who has invested in Fountain Life?

6 investors have backed Fountain Life across its funding rounds, including Eos Venture Partners, Tony Robbins, Peter Diamandis, Bhupendra Modi, Newcross Healthcare and Todd R. Wanek.

Lead investors include Eos Venture Partners and Newcross Healthcare.


Fountain Life Investors

Investors in Fountain Life by funding rounds participated
InvestorHQRoundsRoleFirst check
Eos Venture PartnersUnited KingdomLondon3LeadDec 2022
Todd R. WanekUnited StatesArcadia, WI1ParticipantAug 2025
Tony RobbinsUnited StatesSan Diego, CA1ParticipantAug 2025
Peter DiamandisUnited StatesLos Angeles, CA1ParticipantAug 2025

This data is available for Pro users. Sign up to see all 6 Fountain Life investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Acquisitions by Fountain Life

Fountain Life has acquired 1 company to date.

Last acquisition by Fountain Life was on December 6th 2023. Fountain Life acquired LifeOmic for undisclosed valuation.


Latest Acquisitions by Fountain Life

LifeOmic
Description
LifeOmic is an Indianapolis-based software provider that builds the Precision Health Operating System for oncology and chronic disease management. Its cloud platform integrates machine learning to analyze patient data from electronic health records, wearables, and genomic sequencing. Healthcare providers use LifeOmic tools for clinical trial matching and remote patient monitoring. Researchers access de-identified datasets for studies on precision medicine. The company serves institutions like Indiana University Health and supports mobile apps for patient engagement.
HQ CountryUnited States
HQ City
Indianapolis, IN
Deal Date6 Dec 2023
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Fountain Life acquisitions and their M&A valuation multiples.

Start Free Trial

Fountain Life Competitors

Fountain Life competitors include listed companies like Revvity and JMDC, and private ones like Noom, Sword Health, Pristyn Care and Neko Health.

Public and private companies comparable to Fountain Life
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
NoomUnited StatesNew York City, NYPrivate$400M-$3.7B9.3x
Sword HealthUnited StatesNew York City, NYPrivate$240M-$4B16.7x
Pristyn CareIndiaGurgaonPrivate$64M-$1.4B-
RevvityUnited StatesUnited StatesPublicly listed$2.9B$735M$16B6.6x
Neko HealthSwedenStockholmPrivate--$7B-
JMDCJapanJapanPublicly listed$324M$88M$1.5B4.6x

Fountain Life Public Comps

Fountain Life is still privately-owned, but its public comps include Natera, IQVIA, Agilent, GE HealthCare, Quest Diagnostics, Labcorp, Guardant Health, Revvity, Solventum and Tempus AI.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Natera$2.3B($266M)22.5x19.0x(195.0x)(261.5x)
IQVIA$16B$3.4B3.6x3.4x17.2x14.8x
Agilent$6.9B$1.8B6.7x6.2x26.1x21.0x
GE HealthCare$21B$3.7B1.8x1.8x10.1x10.0x
Quest Diagnostics$11B$2.2B3.0x2.9x15.5x14.5x
Labcorp$14B$2B2.4x2.3x16.3x13.0x
Guardant Health$982M($408M)25.7x20.2x(61.8x)(129.5x)
Revvity$2.9B$735M6.5x6.6x25.4x21.0x

This data is available for Pro users. Sign up to see all Fountain Life competitors and their valuation data.

Start Free Trial

Common questions about Fountain Life

When was Fountain Life founded?Fountain Life was founded in 2020.
Where is Fountain Life headquartered?Fountain Life is headquartered in United States.
Is Fountain Life publicly listed?No, Fountain Life is a private, VC-backed company.
How much funding has Fountain Life raised?Fountain Life has raised $115M across 4 funding rounds.
What was Fountain Life's last funding round?Fountain Life's last funding round was a $18M Series B in August 2025, led by Eos Venture Partners.
Who are Fountain Life's investors?Fountain Life's investors include Eos Venture Partners, Todd R. Wanek, Tony Robbins, Peter Diamandis, Newcross Healthcare and Bhupendra Modi.
Which companies are comparable to Fountain Life?Companies comparable to Fountain Life include Noom, Sword Health, Pristyn Care, Revvity, Neko Health and JMDC.
How many companies has Fountain Life acquired?Fountain Life has acquired 1 company, including LifeOmic.

See companies similar to Fountain Life

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial